difference between tirzepatide and wegovy for Weight Loss Dr. Osipova breaks down the
Description
prediabetes: 31.3%, normoglycemia: 35.1%), one-third received monotherapy (diabetes: 35.0%
Some patients find success with a 'step-down' protocol: maintaining their therapeutic dose for several weeks after goal weight, then reducing by 25% every 2-3 weeks until discontinuation
In a clinical trial in pediatric patients aged 12 years and older for weight reduction, hypotension was reported in 2.3% of WEGOVY-treated patients versus 0% in placebo-treated patients
Q: Does insurance cover this
We know that's not what you wanted to hear, but it's the truth
